A prospective study of transsulfuration biomarkers in autistic disorders - PubMed
A prospective study of transsulfuration biomarkers in autistic disorders
David A Geier et al. Neurochem Res. 2009 Feb.
Erratum in
- Neurochem Res. 2009 Feb;34(2):394
Abstract
The goal of this study was to evaluate transsulfuration metabolites in participants diagnosed with autism spectrum disorders (ASDs). Transsulfuration metabolites, including: plasma reduced glutathione (GSH), plasma oxidized glutathione (GSSG), plasma cysteine, plasma taurine, plasma sulfate, and plasma free sulfate among participants diagnosed with ASDs (n = 38) in comparison to age-matched neurotypical controls were prospectively evaluated. Testing was conducted using Vitamin Diagnostics, Inc. (CLIA-approved). Participants diagnosed with ASDs had significantly (P < 0.001) decreased plasma reduced GSH, plasma cysteine, plasma taurine, plasma sulfate, and plasma free sulfate relative to controls. By contrast, participants diagnosed with ASDs had significantly (P < 0.001) increased plasma GSSG relative to controls. The present observations are compatible with increased oxidative stress and a decreased detoxification capacity, particularly of mercury, in patients diagnosed with ASDs. Patients diagnosed with ASDs should be routinely tested to evaluate transsulfuration metabolites, and potential treatment protocols should be evaluated to potentially correct the transsulfuration abnormalities observed.
Similar articles
-
Biomarkers of environmental toxicity and susceptibility in autism.
Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR. Geier DA, et al. J Neurol Sci. 2009 May 15;280(1-2):101-8. doi: 10.1016/j.jns.2008.08.021. Epub 2008 Sep 25. J Neurol Sci. 2009. PMID: 18817931
-
Han Y, Xi QQ, Dai W, Yang SH, Gao L, Su YY, Zhang X. Han Y, et al. Int J Dev Neurosci. 2015 Nov;46:27-32. doi: 10.1016/j.ijdevneu.2015.06.006. Epub 2015 Jul 3. Int J Dev Neurosci. 2015. PMID: 26150135
-
Oxidative stress-related biomarkers in autism: systematic review and meta-analyses.
Frustaci A, Neri M, Cesario A, Adams JB, Domenici E, Dalla Bernardina B, Bonassi S. Frustaci A, et al. Free Radic Biol Med. 2012 May 15;52(10):2128-41. doi: 10.1016/j.freeradbiomed.2012.03.011. Epub 2012 Apr 18. Free Radic Biol Med. 2012. PMID: 22542447 Review.
-
The role of glutathione redox imbalance in autism spectrum disorder: A review.
Bjørklund G, Tinkov AA, Hosnedlová B, Kizek R, Ajsuvakova OP, Chirumbolo S, Skalnaya MG, Peana M, Dadar M, El-Ansary A, Qasem H, Adams JB, Aaseth J, Skalny AV. Bjørklund G, et al. Free Radic Biol Med. 2020 Nov 20;160:149-162. doi: 10.1016/j.freeradbiomed.2020.07.017. Epub 2020 Jul 31. Free Radic Biol Med. 2020. PMID: 32745763 Review.
Cited by
-
Zheng HF, Wang WQ, Li XM, Rauw G, Baker GB. Zheng HF, et al. Amino Acids. 2017 Jan;49(1):57-65. doi: 10.1007/s00726-016-2332-y. Epub 2016 Sep 29. Amino Acids. 2017. PMID: 27686223 Free PMC article. Review.
-
Strunecka A, Blaylock RL, Patocka J, Strunecky O. Strunecka A, et al. Surg Neurol Int. 2018 Apr 9;9:74. doi: 10.4103/sni.sni_407_17. eCollection 2018. Surg Neurol Int. 2018. PMID: 29721353 Free PMC article. Review.
-
Belalcázar AD, Ball JG, Frost LM, Valentovic MA, Wilkinson J 4th. Belalcázar AD, et al. ISRN Biochem. 2014;2013:637897. doi: 10.1155/2013/637897. ISRN Biochem. 2014. PMID: 24634789 Free PMC article.
-
Wood PL. Wood PL. Neuropsychopharmacology. 2014 Jan;39(1):24-33. doi: 10.1038/npp.2013.167. Epub 2013 Jul 11. Neuropsychopharmacology. 2014. PMID: 23842599 Free PMC article. Review.
-
Anderson G, Maes M. Anderson G, et al. Curr Neuropharmacol. 2014 Mar;12(2):148-67. doi: 10.2174/1570159X11666131120223757. Curr Neuropharmacol. 2014. PMID: 24669209 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources